论文部分内容阅读
【《病学世界报导》1989年2月】在 McGill 大学举行的一次国际性专题讨论会上,会议参加者一致主张对无并发症的急性泌尿道感染,应采用习惯用的可靠的抗生素来治疗,不宜采用广谱的强效的新抗生素。会议主席 Lloyd Harrison 称,在每年5百万的泌尿道感染病例中,大多数是不需要应用强效的抗生素来治疗,因90%的病例都是由大肠杆菌引起的单纯性膀胱炎,采用复方新诺明、羟氨苄青霉素、氨苄青霉素和呋喃妥因巨结晶(Macrodantin)均可奏效,如采用更广谱更昂贵的抗生素简直是过分的做法。
[World of Disease Science February 1989] At an international symposium held at McGill University, participants in the meeting unanimously advocated the treatment of acute urinary tract infections without complications using a well-established and reliable antibiotic , Should not use a broad spectrum of powerful new antibiotics. Lloyd Harrison, chairman of the conference, said most of the 5 million cases of urinary tract infections each year do not require potent antibiotics for treatment, as 90% of cases are simple cystitis caused by E. coli. Sulfamethoxazole, amoxicillin, ampicillin and macrodantin are all effective, making it more than an exaggeration to use a broader spectrum of more expensive antibiotics.